Telocyte


Peter Rayson

Biotechnology Research CEO of the Year 2022 - UK
Peter Rayson founded Telocyte with Michael Fossell, a leader in proposing the use of telomerase to treat age-related disease. Telocyte’s first target is Alzheimer’s; animal trials to begin this year.